KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Long-Term Debt Repayments (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Long-Term Debt Repayments for 17 consecutive years, with $200000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Long-Term Debt Repayments changed N/A to $200000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $500000.0, a 25.0% increase, with the full-year FY2025 number at $500000.0, up 25.0% from a year prior.
  • Long-Term Debt Repayments was $200000.0 for Q4 2025 at Bio-Rad Laboratories, roughly flat from $200000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $1.4 million in Q1 2021 to a low of $100000.0 in Q2 2024.
  • A 5-year average of $273333.3 and a median of $122000.0 in 2021 define the central range for Long-Term Debt Repayments.
  • Peak YoY movement for Long-Term Debt Repayments: plummeted 99.68% in 2021, then skyrocketed 100.0% in 2025.
  • Bio-Rad Laboratories' Long-Term Debt Repayments stood at $1.4 million in 2021, then plummeted by 90.33% to $133000.0 in 2022, then grew by 13.53% to $151000.0 in 2023, then crashed by 33.77% to $100000.0 in 2024, then surged by 100.0% to $200000.0 in 2025.
  • Per Business Quant, the three most recent readings for BIO's Long-Term Debt Repayments are $200000.0 (Q4 2025), $200000.0 (Q2 2025), and $100000.0 (Q1 2025).